Meet Our Team | Overview
Brian Kalish, MD
Brian completed his undergraduate degree in Public Health at Johns Hopkins University, and his MD degree Magna Cum Laude at Harvard Medical School. He pursued Pediatrics and Neonatal-Perinatal Medicine training at Boston Children’s Hospital and postdoctoral research in Neurobiology with Michael Greenberg, PhD, at Harvard Medical School. He was on faculty at the Hospital for Sick Children as a neonatologist and scientist in the Program in Neuroscience and Mental Health and served as the director of research in Neonatology before returning to Boston Children’s Hospital in 2024.
Brian’s research is motivated by the desire to improve the lives of fragile newborns and to prevent or treat neurodevelopmental disorders. In his spare time, he enjoys adventures with his wife (Marykate) and daughter (Nora), including hiking, kayaking, and cycling at any opportunity.
Bharti Kukreja, PhD
Bharti joined the Kalish Lab in 2021. She did her Master’s degree in Molecular Biology and Biochemistry at Guru Nanak Dev University, India. She has more than eight years of experience in a multidisciplinary research environment with strong knowledge of molecular techniques, next generation sequencing methodologies, and spatial biology. She is well versed in computational analysis of sequencing and spatial data.
Sami Gritli, MD, PhD
Sami earned his MD degree from the Faculty of Medicine of Tunis (Tunis, Tunisia) and PhD degree in molecular and cell biology from the University of Nice-Sophia Antipolis, (Nice, France). He went through a residency in medical genetics at the Pasteur Institute and Gustave Roussy Institute (France), and a fellowship in Genetics at Harvard Medical School (Boston, Massachusetts).
Among a plethora of genetic disorders, inborn errors of development interest Sami the most, thus, developmental biology is his passion. Sami aims at deciphering the fundamental mechanisms by which genes act in concert during embryonic and fetal development, as well as postnatal homeostasis. Sami is currently exploring the fascinating world of neurogenesis in health and disease by using stem cells, next-generation sequencing technologies and animal models. Sami's ultimate goal is to contribute to mechanistic discoveries that will translate into effective treatments that will improve the daily life of children affected with disabling genetic conditions.